Analysis of context-specific KRAS-effector (sub)complexes in Caco-2 cells

Camille Ternet1,2, Philipp Junk1,2, Thomas Sevrin1,2

  • 1Systems Biology Ireland, School of Medicine, University College Dublin, Dublin 4, Ireland.

Life Science Alliance
|March 9, 2023
PubMed

Insights

Environmental conditions significantly alter KRAS protein interactions, impacting cell behavior and potentially explaining tissue-specific cancer development. This study reveals context-dependent network rewiring in KRAS signaling.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Cancer Research

Background:

  • Ras proteins act as crucial molecular switches regulating cell behavior.
  • Understanding the molecular details of Ras-effector complexes and their context-dependent alterations is limited.
  • KRAS signaling pathways are implicated in various cellular functions and diseases, including cancer.

Purpose of the Study:

  • To investigate the impact of genetic and environmental contexts on KRAS effector complex formation.
  • To identify context-general and context-specific KRAS effectors.
  • To elucidate how KRAS interactome changes influence cellular functions like metabolism and proliferation.

Main Methods:

  • Affinity purification coupled with mass spectrometry (AP-MS) was used to identify KRAS interactors.
  • Experiments involved exogenously expressed FLAG-KRAS wild-type and oncogenic mutants in Caco-2 cells.
  • Cells were cultured in diverse media mimicking colon and colorectal cancer conditions.

Main Results:

  • Four context-general and seven context-specific KRAS effectors were identified.
  • Culture conditions exerted a greater influence on KRAS interaction rewiring than genetic mutations.
  • Functional validation confirmed context-dependent differences in cell metabolism and proliferation.

Conclusions:

  • Environmental contexts significantly rewire KRAS-effector networks, impacting cellular functions.
  • This context-dependent network rewiring provides insights into tissue-specific signaling mechanisms.
  • The findings may explain why KRAS oncogenic mutants cause cancer in specific tissues.